💨 Abstract

Atyr Pharma Inc. reported a $19.5 million loss for the second quarter, missing analysts' expectations of 18 cents per share loss with an actual loss of 22 cents per share. Despite the loss, the company's shares have surged 45% since the beginning of the year, closing at $5.24 on Thursday, almost tripling over the past 12 months.

Courtesy: WTOP Staff